Zobrazeno 1 - 10
of 15
pro vyhledávání: '"James Kiguli"'
Autor:
Israel Kiiza Njovu, Pauline Petra Nalumaga, Lucas Ampaire, Edwin Nuwagira, James Mwesigye, Benson Musinguzi, Kennedy Kassaza, Kabanda Taseera, James Kiguli Mukasa, Joel Bazira, Jacob Stanley Iramiot, Andrew Baguma, Felix Bongomin, Richard Kwizera, Beatrice Achan, Michael J Cox, Jason S King, Robin May, Elizabeth R Ballou, Herbert Itabangi
Publikováno v:
JMIR Research Protocols, Vol 12, p e48014 (2023)
BackgroundFungal-bacterial cocolonization and coinfections pose an emerging challenge among patients suspected of having pulmonary tuberculosis (PTB); however, the underlying pathogenic mechanisms and microbiome interactions are poorly understood. Un
Externí odkaz:
https://doaj.org/article/fa0c2c8e627a4ba6a4ab13720d7fa50c
Autor:
Israel Kiiza Njovu, Benson Musinguzi, James Mwesigye, Kennedy Kassaza, Joseph Turigurwa, Edwin Nuwagira, Joel Bazira, Taseera Kabanda, Moses Mpeirwe, Lucas Ampaire, Andrew Mutekanga, James Kiguli, Beatrice Achan, Herbert Itabangi
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 8 (2021)
Background: Pulmonary mycoses are important diseases of the respiratory tract caused by pulmonary fungal pathogens. These pathogens are responsible for significant morbidity and mortality rates worldwide; however, less attention has been paid to them
Externí odkaz:
https://doaj.org/article/e49b97c075ca4c00b21ea315288c530c
Autor:
Kennedy Kassaza, Joel Bazira, Lucas Ampaire, Joseph Turigurwa, Edwin Nuwagira, Herbert Itabangi, Israel Kiiza Njovu, Moses Mpeirwe, Beatrice Achan, Taseera Kabanda, James Kiguli, Andrew Mutekanga, James Mwesigye, Benson Musinguzi
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 8 (2021)
Therapeutic Advances in Infectious Disease
Therapeutic Advances in Infectious Disease
Background: Pulmonary mycoses are important diseases of the respiratory tract caused by pulmonary fungal pathogens. These pathogens are responsible for significant morbidity and mortality rates worldwide; however, less attention has been paid to them
Autor:
Beatrice Achan, Andrew Mutekanga, Kennedy Kassaza, Israel Kiiza Njovu, Lucas Ampaire, Moses Mpeirwe, Edwin Nuwagira, Joel Bazira, James Mwesigye, Joseph Turigurwa, Benson Musinguzi, Herbert Itabangi, Taseera Kabanda, James Kiguli
Background: Pulmonary mycoses are very important diseases of the respiratory tract and are responsible for significant morbidity and mortality rates worldwide. However less attention has been paid to them. In this study we determined the prevalence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34e175e611415ea5baaea6f06252a913
https://doi.org/10.21203/rs.3.rs-523551/v1
https://doi.org/10.21203/rs.3.rs-523551/v1
Autor:
Martha Nakaye, Victoria Katawera, Jacob Stanley Iramiot, Bashir Mwambi, Fredrick Byarugaba, Herbert Itabangi, James Kiguli, Joel Bazira, Victoria Nyaitera
Publikováno v:
International Journal of TROPICAL DISEASE & Health. 32:1-9
Autor:
Musisi John Stephen, Patrick Orikiriza, Nambafu Joan, Mwambi Bashir, James Kiguli, Joel Bazira, Iramiot Jacob Stanley, Herbert Itabangi
Publikováno v:
British Microbiology Research Journal. 7:109-117
1 Department of Biological Sciences, Kyambogo University, Pox Box 1 Kyambogo, Uganda. Kampala City Trader’s Abattoir, Old Portbell Road, Industrial Area P.O.Box 36111 Kampala Uganda. 3 Department of Medical Laboratory Science, Institute of Allied H
Autor:
Walter R. J. Taylor, Piero Olliaro, Kefas Mugittu, Jean-Paul Guthmann, Gerardo Priotto, Hassan Mshinda, Hans-Peter Beck, James Kiguli, Martin Adjuik, Georges Snounou
Publikováno v:
Tropical Medicine & International Health. 12:219-223
Polymerase chain reaction (PCR) genotyping of malaria parasites in drug efficacy trials helps differentiate reinfections from recrudescences. A combination therapy trial of one (n = 115) or three (n = 117) days artesunate (1AS, 3AS 4 mg/kg/day) plus
Autor:
Juliet Kyomuhendo, Francis Bajunirwe, James Kiguli, Francesco Checchi, Isaac Kigozi, Eugene Ruzagira, Walter R. J. Taylor, Joseph B. Babigumira, Patrice Piola, Laurent Ferradini, Jean Paul Guthmann, Carole Fogg, Samuel Biraro, Francesco Grandesso
Publikováno v:
The Lancet. 365:1467-1473
Summary Background The six-dose regimen of artemether-lumefantrine is effective and is among combination therapies prioritised to replace antimalarials that no longer work in Africa. However, its effectiveness has not been assessed in the field, and
Autor:
Francesco Checchi, Joy Musabe, Francis Bajunirwe, Patrice Piola, Agnes Kyomugisha, James Kiguli, Jean-Paul Guthmann, Carole Fogg, Proscovia Namiiro, Samuel Biraro
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 71:525-530
Measuring baseline levels of adherence and identifying risk factors for non-adherence are important steps before the introduction of new antimalarials. In Mbarara in southwestern Uganda, we assessed adherence to artemether-lumefantrine (Coartem) in i
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 96:254-257
A study was conducted to measure the overall performance of several rapid diagnostic tests for Plasmodium falciparum infection, in order to select the most appropriate test to be used in the field. A total of 742 patients attending the out-patient de